Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-039899
Filing Date
2020-07-01
Accepted
2020-07-01 18:16:30
Documents
1
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6671
  Complete submission text file 0001209191-20-039899.txt   8131
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Robbins Wendye (Reporting) CIK: 0001791244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 201006394